Theoretically Based Mobile App to Increase PrEP Uptake Among MSM

Status: Completed
Location: See all (3) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is a randomized controlled clinical trial of a theoretically based mobile app, HealthMindr, to increase pre-exposure prophylaxis (PrEP) uptake among men who have sex with men (MSM) to prevent human immunodeficiency virus (HIV). Participants in the intervention arm will receive access to the HealthMindr app, with information about PrEP and other HIV prevention methods in addition to provider locators. Participants randomized to the control arm will receive standard of care. The primary aim for this study is to assess PrEP uptake in the intervention arm compared to the control arm.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Maximum Age: 34
Healthy Volunteers: t
View:

• Cisgender male

• 18-34 years of age (inclusive)

• Resides in one of the study MSAs

• Intends to remain in study area for duration of the trial

• Owns an Android or Apple operating system (iOS) smartphone and willing to download study app

• Able to read and understand English without assistance

• Reports having anal sex with a man in the past 6 months

• Reports being HIV negative or never tested for HIV

Locations
United States
Washington, D.c.
George Washington University
Washington
Georgia
Emory University
Atlanta
Mississippi
University of Mississippi Medical Center
Jackson
Time Frame
Start Date: 2020-01-28
Completion Date: 2023-03-17
Participants
Target number of participants: 658
Treatments
Experimental: HealthMindr App
Participants in the intervention arm will receive access to all HealthMindr app capabilities. The app information will cover the importance of testing, links to HIV prevention resources, resources to locate HIV testing and PrEP services, the Substance Abuse and Mental Health Services Administration (SAMHSA) substance abuse treatment resource locator, and other prevention information specific to their area.
Placebo_comparator: Control App
Participants in the control arm will be directed to download a study app that allows study staff to interact with them.
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)
Leads: Emory University

This content was sourced from clinicaltrials.gov